ITK-targeted immune remodeling enhanced the efficacy of anti-CD19 CAR-T cell therapy. - Li Z; Lv L; Yao X; Feng Z; Xie Y; Li K; Qi F; Yang M; Wang J; Pan T; Li X; Chen H; et al. (Cell death discovery, 2026)